Status:

WITHDRAWN

Mapping 3D Bladder

Lead Sponsor:

University Health Network, Toronto

Conditions:

Bladder Cancer

Eligibility:

All Genders

18-100 years

Brief Summary

This is a single centre, single arm feasibility study assessing the feasibility of using computer vision methods to recreate the 3D bladder shape and to then map the cystoscopy images onto this bladde...

Eligibility Criteria

Inclusion

  • 18 years of age or older.
  • Clinical suspicion or histologic diagnosis of bladder tumour suitable for endoscopic evaluation.
  • Intention to treat using external beam radiation therapy as part of standard of care.
  • Ability to provide written informed consent to participate in the study.

Exclusion

  • Prior complete or partial radiation therapy to bladder.
  • Contraindications to radiation therapy as determined by the treating physician.
  • Concurrent illness or condition that precludes subject from undergoing endoscopy or CT scanning.

Key Trial Info

Start Date :

March 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2025

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT05260788

Start Date

March 1 2022

End Date

March 1 2025

Last Update

April 14 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Princess Margaret Cancer Centre

Toronto, Ontario, Canada, M5G 2M9